| NCT06963710 | A Study Evaluating the Efficacy and Safety of ALG-000184 Compared With Tenofovir Disoproxil Fumarate in Untreated HBeAg-Positive and HBeAg- Negative Adult Subjects With Chronic Hepatitis B (B-SUPREME) | RECRUITING | PHASE2 | 2025-07-15 | 2028-08 | 2027-03 |
| NCT06959888 | A Phase 1 Study in Healthy Volunteers to Evaluate the Relative Bioavailability of ALG-055009 Formulations | COMPLETED | PHASE1 | 2025-03-25 | 2025-05-16 | 2025-05-08 |
| NCT06698549 | A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ALG-097558 in Subjects with Renal Impairment and in Healthy Subjects with Normal Renal Function | RECRUITING | PHASE1 | 2025-02-01 | 2026-02 | 2025-11 |
| NCT06568861 | A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ALG-097558 in Subjects with Hepatic Impairment and in Healthy Subjects with Normal Hepatic Function | RECRUITING | PHASE1 | 2025-01-14 | 2025-05 | 2025-04 |
| NCT06672900 | A Multi-part Study of ALG-000184 to Evaluate Safety, Tolerability, Pharmacokinetics and Drug-drug Interaction Potential After Single and Multiple Doses in Healthy Volunteers | ACTIVE_NOT_RECRUITING | PHASE1 | 2025-01-09 | 2025-07-07 | 2025-07-07 |
| NCT06342947 | ALG-055009 in Non-cirrhotic Adults With MASH (HERALD) | COMPLETED | PHASE2 | 2024-04-01 | 2024-09-09 | 2024-08-19 |
| NCT06191991 | A Phase 1 Study to Evaluate the Drug-Drug Interaction Potential Between ALG-055009 and Statin Therapy(Ies) | COMPLETED | PHASE1 | 2023-11-03 | 2023-12-04 | 2023-11-27 |
| NCT05840952 | A First-in-Human Multi-Part Phase 1 Study in Healthy Volunteers to Evaluate the Safety, Tolerability, Pharmacokinetics, and Drug-Drug Interaction Potential of Single and Multiple Doses of ALG-097558 | COMPLETED | PHASE1 | 2023-07-04 | 2024-04-29 | 2024-04-29 |
| NCT05561530 | A Study of ALG-125755 to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics After Single Doses in Healthy Volunteers, and Single and Multiple Doses in CHB Subjects | TERMINATED | PHASE1 | 2022-10-07 | 2023-06-15 | 2023-06-15 |
| NCT05090111 | A Study of ALG-055009 in Healthy Volunteers and Subjects With Hyperlipidemia | COMPLETED | PHASE1 | 2021-12-01 | 2023-06-16 | 2023-06-16 |
| NCT05001022 | A Study of ALG-020572 Drug to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Single Doses in Healthy Volunteers and Multiple Doses in CHB Subjects | TERMINATED | PHASE1 | 2021-09-25 | 2022-07-18 | 2022-07-18 |
| NCT04536337 | A Study of ALG-000184 Drug to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Single and Multiple Doses in Healthy Volunteers and CHB Subjects | ACTIVE_NOT_RECRUITING | PHASE1 | 2020-10-22 | 2025-06-16 | 2025-06-16 |
| NCT04485663 | A Study of ALG-010133 Drug to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Single and Multiple Doses in Healthy Volunteers and CHB Subjects | TERMINATED | PHASE1 | 2020-08-17 | 2022-03-08 | 2022-03-08 |